Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | -2.91% | -8.26% | -5.70% |
Financials (USD)
Sales 2022 | 2.92M | Sales 2023 | 5K | Capitalization | 16.98M |
---|---|---|---|---|---|
Net income 2022 | -37M | Net income 2023 | -35M | EV / Sales 2022 | 46.5 x |
Net cash position 2022 | 19.55M | Net cash position 2023 | 6.06M | EV / Sales 2023 | 2,184 x |
P/E ratio 2022 |
-3.74
x | P/E ratio 2023 |
-0.48
x | Employees | 1 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 85.7% |
Latest transcript on Alaunos Therapeutics, Inc.
1 day | -2.91% | ||
1 week | -8.26% | ||
Current month | -8.26% | ||
1 month | -24.24% | ||
3 months | -47.37% | ||
6 months | +16.96% | ||
Current year | -5.70% |
Managers | Title | Age | Since |
---|---|---|---|
Dale Hogue
CEO | Chief Executive Officer | 54 | Dec. 28 |
Director of Finance/CFO | 62 | 21-02-16 | |
Melinda Lackey
ADM | Chief Administrative Officer | 47 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jaime Vieser
BRD | Director/Board Member | 54 | 20-12-15 |
Holger Weis
CHM | Chairman | 61 | 20-12-15 |
Robert Postma
BRD | Director/Board Member | 70 | 21-02-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1 | -2.91% | 54,185 |
24-06-06 | 1.03 | -3.74% | 17,100 |
24-06-05 | 1.07 | -0.93% | 28,545 |
24-06-04 | 1.08 | -2.70% | 10,438 |
24-06-03 | 1.11 | +1.83% | 19,917 |
Delayed Quote Nasdaq, June 07, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-5.70% | 16.01M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- TCRT Stock